objective response rate

13 papers and 1 presentation; 14 titles.

Back to keywords

Conference ×	Year ×	Title ×	Authors	Extras	Pages
PHUSE US	2026	Advancing Precision Medicine and Regulatory Readiness: Data Harmonisation and Statistical Methods for Companion Diagnostics Bridging Studies	Ummul Vara Qurratul Ain	source presentation source	10
PHUSE US	2026	Group, Collapse, Repeat: A Dynamic SAS Macro for Stratification Pooling in Oncology Efficacy Analysis	Venkatesh Burla	source presentation source	9
PHUSE US	2026	The Journey of Deriving the Best Overall Response (BOR) for Solid Tumours - A Programmer's Perspective	Milan Adesara, Vishal Gandhi	source poster source	7
PharmaSUG	2025	Deciphering Exposure-Response Analysis Datasets: A Programmer-s Perspective for Oncology Studies	Sabarinath Sundaram	source	6
PharmaSUG	2025	Efficacy Endpoints Related to CNS in Oncology Studies within ADaM	Lihui Deng, Kylie Fan	source	6
PharmaSUG	2025	Mastering the Maze of Oncology Endpoints: A Unified SAS Approach for Randomized Controlled Trial Analysis	Yuxin Wang, Kelly Chao, Wenqing Yu, Hongbing Jin	source	11
PharmaSUG	2024	ADaM Design for Prostate Cancer Efficacy Endpoints Based on PCWG3	Lihui Deng, Kylie Fan, Jia Li	source	10
PHUSE EU	2021	How Has the Immunotherapy Era Changed Response Criteria? [presentation]	Anna Amosova	source video	30
PharmaSUG	2020	Calculation of Cochran-Mantel-Haenszel Statistics for Objective Response and Clinical Benefit Rates and the Effects of Stratification Factors	Girish Kankipati, Chia-Ling (Ally) Wu	source	8
PharmaSUG	2019	Useful SAS techniques in Efficacy Analysis for Oncology studies	Joy Zeng	source	21
PHUSE EU	2018	Step-by-step Guide to Efficacy Analysis in Solid Tumors Oncology Clinical Trials	Anastasiia Tiurdo	source presentation source	11
PharmaSUG	2018	Leveraging Standards for Effective Visualization of Early Efficacy in Clinical Trial Oncology Studies	Kelci J. Miclaus, Lili Li	source	12
PharmaSUG	2015	Two different use cases to obtain best responses using RECIST 1.1: SDTM and ADaM	Kevin Lee, Vikash Jain	source	17
PHUSE EU	2013	Efficacy Endpoints in Oncology	Angelo Tinazzi	source	9

Back to keywords